Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Patient-held tools supporting gestational diabetes mellitus (GDM) care across the perinatal continuum: a scoping review.

Created on 01 Nov 2026

Authors

Aimen Zehra, Katelyn Sushko, Diana Sherifali, Sandhya Sahye-Pudaruth, Apishanthi Sriskandarajah, Sameen Ali, Lorraine L Lipscombe

Published in

Diabetes research and clinical practice. Pages 113642. Oct 31, 2026. Epub Oct 31, 2026.

Abstract

Gestational diabetes mellitus (GDM) requires continuous care across the perinatal period, yet fragmented systems create gaps in follow-up and coordination. Patient-held tools support self-management and continuity, but their scope across the perinatal continuum has not been synthesized. We conducted a scoping review following Arksey and O'Malley guidelines, searching five databases (MEDLINE, EMBASE, PsycINFO, CINAHL, Web of Science) from January 2000 to November 2025. Two reviewers independently screened and extracted data on patient-held GDM tools in pregnancy, postpartum, or both. 62 studies from 24 countries were included. Most tools were mobile applications (n = 48, 77%), predominantly targeting the prenatal period (n = 44, 71%). Common features included glucose monitoring, education, and provider communication. Some studies reported improvements in glycemic control, engagement, and satisfaction, though implementation outcomes (n = 48, 77%) were more commonly reported than clinical outcomes (n = 28, 45%). Only 12 unique tools supported prenatal-to-postpartum continuity. Key barriers included health literacy, technological limitations, and health system challenges; facilitators included personalized content, ease of use, and real-time visual feedback. Patient-held tools show promise for short-term outcomes; however, continuity of care remains infrequently reported, possibly reflecting gaps in tool design, reporting, or both. Future tools should address equity barriers and incorporate continuity mechanisms to reduce long-term cardiometabolic risk.

PMID:
42966405
Bibliographic data and abstract were imported from PubMed on 01 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement